Cellular, biochemical and molecular changes in muscles from patients with X-linked myotubular myopathy due to MTM1 mutations.

Bachmann C, Jungbluth H, Muntoni F, Manzur AY, Zorzato F, Treves S. Hum Mol Genet. 2016 Dec 22. pii: ddw388.

22 dicembre 2016

Muscle PGC-1α modulates satellite cell number and proliferation by remodeling the stem cell niche.

Dinulovic I, Furrer R, Beer M, Ferry A, Cardel B, Handschin C. Skelet Muscle. 2016 Dec 2;6(1):39.

02 dicembre 2016

Effects of Neuromuscular Electrical Stimulation Training on Endurance Performance

Veldman MP, Gondin J, Place N, Maffiuletti NA. Front Physiol. 2016 Nov 16;7:544

30 novembre 2016

NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation.

Ryu D, Zhang H, Ropelle ER, Sorrentino V, Mázala DA, Mouchiroud L, Marshall PL, Campbell MD, Ali AS, Knowels GM, Bellemin S, Iyer SR, Wang X, Gariani K, Sauve AA, Cantó...

21 ottobre 2016

Caloric restriction induces energy-sparing alterations in skeletal muscle contraction, fiber composition and local thyroid hormone metabolism that persist during catch-up fat upon refeeding.

De Andrade PB, Neff LA, Strosova MK, Arsenijevic D, Patthey-Vuadens O, Scapozza L, Montani JP, Ruegg UT, Dulloo AG, Dorchies OM. OM.Front Physiol. 2015 Sep 16;6:254

07 ottobre 2016

Santhera Starts Phase III Study (SIDEROS) with Raxone in Patients with Duchenne Muscular Dystrophy Using Glucocorticoids

28 settembre 2016

New and emerging roles of small RNAs in neurodegeneration, muscle, cardiovascular and inflammatory diseases.

Hruska-Plochan M, Li B, Kyburz D, Krützfeld J, Landmesser U, Aguzzi A, Polymenidou M. Swiss Med Wkly. 2015 Sep 16;145:w14192.

16 settembre 2016

Somatic Therapy of a Mouse SMA Model with a U7 snRNA Gene Correcting SMN2 Splicing.

Odermatt P, Trüb J, Furrer L, Fricker R, Marti A, Schümperli D. Mol Ther. 2016 Aug 30.

13 settembre 2016

Current and future therapeutic approaches to the congenital myopathies.

Jungbluth H, Ochala J, Treves S, Gautel M. Semin Cell Dev Biol. 2016 Aug 8.

08 settembre 2016

Santhera erhält FDA-Förderbeitrag zur Unterstützung der laufenden Phase-I-Studie mit Omigapil bei kongenitaler Muskeldystrophie

Press release August 30th, 2016

30 agosto 2016